NGS Vs PCR for EGFR genotyping in NSCLC

Detectability of uncommon EGFR mutations in NSCLC: NGS versus PCRПодробнее

NGS provides improved identification of uncommon EGFR mutations over PCR in NSCLCПодробнее

Lung cancer genotyping with NGSПодробнее

Tracy Stockley - Variant detection in cell-free DNA from NSCLC using NGSПодробнее

Detection of EGFR mutations in plasma cfDNA and CTCs of NSCLC patients using Crystal Digital PCR™Подробнее

Significance of Next-Generation Sequencing in NSCLCПодробнее

Molecular Testing for EGFR Mutations: What Pathologists Need to KnowПодробнее

Plasma Genotyping Platforms: Strengths and LimitationsПодробнее

A Comparison Study between ARMS PCR vs NGS for detection of EGFR Exon20ins in NSCLCПодробнее

Using Digital PCR to Verify NGS for Cancer Research | ASHG 2015Подробнее

Use of PCR, IHC, and NGS to Guide TherapyПодробнее

Next-Generation Sequencing in Patients With NSCLCПодробнее

Blood-based detection: EGFR/ KRAS mutations for NSCLC patients using multiplexed droplet digital PCRПодробнее

Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLCПодробнее

Liquid Biopsy and Next-Generation SequencingПодробнее

Dr. Wakelee on Importance of NGS Testing in NSCLCПодробнее

Plasma Testing for NSCLC EGFR & ALK MutationsПодробнее

NGS & single-gene testing: lung cancerПодробнее

Next generation sequencing in lung cancerПодробнее